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Influence of age on rat bone-
marrow mesenchymal stem cells 
potential
J. Fafián-Labora1, P. Fernández-Pernas1, I. Fuentes1, J. De Toro1, N. Oreiro2, S. Sangiao-
Alvarellos3, J. Mateos1 & M.C. Arufe1
Mesenchymal stem cells promising role in cell-based therapies and tissue engineering appears to be 
limited due to a decline of their regenerative potential with increasing donor age. Six age groups 
from bone marrow mesenchymal stem cells of Wistar rats were studied (newborn, infant, young, 
pre-pubertal, pubertal and adult). Quantitative proteomic assay was performance by iTRAQ using 
an 8-plex iTRAQ labeling and the proteins differentially expressed were grouped in pluripotency, 
proliferative and metabolism processes. Proliferation makers, CD117 and Ki67 were measure by 
flow cytometry assay. Real time polymerase chain reaction analysis of pluripotency markers Rex1, 
Oct4, Sox2 and Nanog were done. Biological differentiation was realized using specific mediums 
for 14 days to induce osteogenesis, adipogenesis or chondrogenesis and immunostain analysis of 
differentiated cell resulting were done. Enzimoimmunoassay analysis of several enzymes as L-lactate 
dehydrogenase and glucose-6-phosphate isomerase were also done to validate iTRAQ data. Taking 
together these results indicate for the first time that mesenchymal stem cells have significant 
differences in their proliferative, pluripotency and metabolism profiles and those differences are age 
depending.
Mesenchymal Stem Cells (MSCs) have self-renewal capacity and multiple differentiation potentials, and 
a priori, could play important roles in regenerative medicine. The promising role of MSCs in cell-based 
therapies is their trophic, paracrine and immunomodulatory functions that may have the greatest ther-
apeutic impact in vivo1,2. Tissue engineering from MSCs are of highly importance for regeneration of 
mesenchymal tissues such as craniofacial bone3, cartilage4 and connective tissues5.
Since several years ago, numerous studies have shown that MSCs from different tissues have similar 
levels of surface antigen expression, immunosuppressive activity, and differentiation ability6. The ability 
of MSC to carry out normal tissue regeneration in the body and their potential for using in clinical 
applications may be impaired by loss of stem cell number and function with age7. There are different rate 
of cell proliferation and clonality between MSCs depending of source from the cells are obtained8 and 
the chronological age form the donors and also the number of the in vitro culture passages9. MSCs are 
missing their characteristics during the chronological or in vitro culture of them10 but not in the same 
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way. Various attempts have been made to address challenges associated with aging of MSC including 
culture in hypoxic conditions11 and ectopic expression of pluripotency-associated factors12. This study 
applied the 8-plex iTRAQ system to analyze MSCs from six different aging groups, as this quantitative 
proteomic technology has the capability to compare several time points in a single experiment.
The major contributor to the development of the senescent cellular phenotype is hyper activation of 
nutrient sensor and growth pathways, in particular mTOR and its derivative complexes mTORC1 and 
mTORC213,14. mTOR family regulates senescence and autophagy during reprogramming of somatic cells 
to pluripotency indicating the important role of energy metabolism to stem cell renewal and aging15. We 
studied the relationship between mTOR and the proliferation markers CD117 and Ki67 using imatinib 
mesylate, the inhibitor of tyrosine kinase receptor for CD11716 and JK184 which reduce expression of 
Ki6717. We establish a framework for future comparative and functional studies; we have analyzed the 
phenotypic, genotypic features and biological-related changes in MSCs of rat bone marrow from animals 
of different ages.
Material and Methods
Isolation and culture of cells. For isolation of MSCs, the animals were anesthetized with Fluorane 
(Izasa, A Coruña, SP) and sacrificed by cervical dislocation method. Femurs were dissected from male 
Wistar rat (Animal Service, CHUAC) at different ages: neonate (0 days old), infant (7 days old), young 
(14 days old), pre-pubertal (35–38 days old), pubertal (45 days old) and adult (2 months old). All the 
methods were carried out in “accordance” with the approved guidelines of Spanish law (32/2007). All 
experimental protocols were approved by Animal Ethical Committee of Galicia. The protocol used by 
Karaoz et al.18 was followed in this work. Briefly, the ends of the bones were cut away and a 21-gauge nee-
dle that was inserted into shaft of the bone marrow was extruded by flushing with 5 ml D-Hank’s solution 
supplemented with 100 IU/ml penicillin–100 mg/ml streptomycin (all from Life Technologies, Madrid, 
Spain). Marrow plug suspension was dispersed by pipetting, successively filtered through 70-μ m mesh 
nylon filter (BD Biosciences, Bedford, MA, USA), and centrifuged at 20000 g for 10 min. Supernatant 
containing thrombocytes and erythrocytes was discarded, and the cell pellet was resuspended in the 
medium. The cells from four rats were seeded onto 100 cm2 dish plate (TM Nunclon) and incubated 
at 37 °C with 5% humidified CO2. The MSCs were isolated on the basis of their ability to adhere to the 
culture plates. On the third day, red blood cells and other non-adherent cells were removed and fresh 
medium was added to allow further growth. The adherent cells grown to 70% confluence were defined 
as passage zero (P0) cells. After 5 min of centrifugation, 1 × 106 MSCs were seeded on two dish plates 
100 cm2 (TM Nunclon) in RPMI supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin 
and 100 mg/ml streptomycin (all from Sigma-Aldrich, St. Louis, MO, USA). The medium was added 
and replaced every 3 or 4 days for 2 weeks. Before being used in inducing mesoderm differentiation, the 
MSCs had been expanded for 2 passages and characterized. Afterwards MSCs from adult group were 
incubated during 12 hours previously to protein extraction with imatinib mesylate or JK184 (all from 
Sigma-Aldrich).
Flow Cytometry. To characterize the different populations of MSCs from chronological different 
animals, their MSCs were washes twice in PBS (Sigma-Aldrich, St. Louis, MO, USA), then pre-blocked 
with 2% rat serum in PBS. The following direct antibodies were used: PE-conjugated mouse anti-human 
CD34 (1:20 from DakoCytomation, Barcelona, SP); FITC-conjugated mouse anti-rat CD45 (1:20 
BD Pharmingen, New Jersey, USA); PE-Cy5.5-conjugated mouse anti-rat CD90 (1:20 Immunostep, 
Salamanca, SP) and APC-conjugated mouse anti-rat CD29 (1:20 Immunostep, Salamanca, SP). The cells 
were washed with PBS after one hour of incubation with the corresponding antibody at room temper-
ature. To check proliferation profile of the different populations of MSCs from chronological different 
animals, their MSCs were incubated with APC conjugated mouse anti-rat CD117 (1:20 Immunostep, 
Salamanca, SP), mouse anti-BRDU (sigma-Aldrich) and FITC conjugated mouse anti-human Ki67 (1:20 
Immunostep, Salamanca, SP). The secondary FITC-conjugated rabbit anti-mouse antibody was used to 
link cells incubated with anti-BRDU. The stained cells were then washed twice with PBS and 2 × 105 cells 
were analyzed with a FACSAria flow cytometer (BD Science, Madrid, SP). FACS data was generated by 
DIVA software (BD Science). Negative control staining was performed using FITC-conjugated mouse 
IgG1K isotype, PE- conjugated mouse IgG1K isotype, PE-Cy5.5- conjugated mouse IgG1K isotype and 
APC- conjugated mouse IgG1K isotype (all from BD Pharmingen). For the intracellular ROS accumu-
lation was used H2DCFDA. Upon oxidation by ROS, the non-fluorescent H2DCFDA is converted to 
the highly fluorescent 2′,7′-dichlorofluorescein. MitoSOX™ Red Reagent was used to determine mito-
chondrial ROS including superoxide dismutase activity. Tetramethylrhodamine, methyl ester (TMRM) 
(from Thermo Fisher Scientific, Life Technologies, SP), the permanent dye that accumulates in active 
mitochondria with intact potentials, was used to detect functional mitochondria in the MSCs at different 
ages following functional mitochondrial staining protocol from commercial.
Proliferation assay. Different numbers of cells (0, 1000, 2000, 4000, 8000 and 16000 cells), were 
plated in triplicate in 96-well plates and allowed to adhere for 8 hours, were used to calculate the prolifer-
ation curve. The number of cells was then calculated using CellTiter 96® AQueous Non-Radioactive Cell 
Proliferation Assay (Promega, Madison, WI, USA) following manufacturer instructions. For the assay, 
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4000 cells were plated for each cell line in triplicate in 96-well plates, and the total number of cells was 
calculated at different time points (0, 1, 2, 5 and 6 days).
The cytotoxicity assay was realized using Cell Counting Kit-8 (Dojindo Molecular Technologies, Inc. 
MD 20850, USA). Briefly 100 all of cell suspension (5000 cells/well) in a 96-well plate were incubated for 
24 hours at at 37 °C, 5% CO2. After that medium with imatinib mesylate or JK184 was added to the wells 
48 hours later, 10 μ l of CCK-8 solution was added to each well of the plate. After four hours incubation 
the absorbance was measured at 450 nm using a microplate reader.
Histological and immunohistochemical analysis. MSCs following differentiation into 
chondrocyte-like or adipocyte-like cells were frozen in OCT embedding matrix (BDH Chemicals, Poole, 
UK). The cells were fixed in 4% (w/v) paraformaldehyde (Sigma-Aldrich) in PBS at pH 7.6. Some cells 
were stained with Safranin O, Modified Masson´s (Sigma-Aldrich) to evaluate the distribution of prote-
oglycan in the extracellular matrix generated by the cells differentiated towards chondrocyte-like cells. 
Other cells were stained with Alizarin red (Sigma-Aldrich) to check alkaline deposits in cells differenti-
ated towards osteocyte-like cells. Other cells were stained with Oil red (Sigma-Aldrich) to check oil drops 
in cells differentiated towards adipocyte-like cells.
Densitometry analysis. AnalySIS Image Processing (Soft Imaging system GmbH V. 5.0, Olympus, 
Münster, Germany) was used to do a densitometry quantification of the staining obtained by immuno-
histochemistry analysis shown in the plots. Three fields 200 mm2 in size from each inmunostain- safra-
nine O, oil red, modified Masson’s and alizarin red - and time studied were quantified using arbitrary 
units for immunohistochemistry values provided by the computer program. Values expressed as percent-
age of positive stain for each marker studied were used for immunohistochemistry analysis. All values 
were referenced with respect to values obtained from cells cultured in the control medium (RPMI 5% 
knockout serum, 1% penicillin and 1% streptomycin).
Real time quantitative polymerase chain reaction (qRT-PCR) analysis. Primers for amplifica-
tion of rat Rex1, Oct4, Sox2 and Nanog genes were used to determine the expression of those markers 
for pluripotency in the different populations of MSCs from chronological different animals. Details are 
shown in Table 1. The amplification program consisted of initial denaturation at 92 °C for 2 minutes fol-
lowed by 40 cycles from 92 °C for 15 seconds, annealing at 55–62 °C, depending on the gene, for 30 sec-
onds and extension at 72 °C for 15 seconds. PCR analyses were done in triplicate, with each set of assays 
repeated three times. To minimize the effects of unequal quantities of starting RNA and to eliminate 
potential sources of inconsistency, relative expression levels of each gene was normalized to ribosomal 
protein (HPRT) using the 2-Δ Δ Ct method19. Control experiments utilized no reverse transcriptase.
Protein isolation and immunoblot analysis. Immunoblot analysis was performed on 40 μ g of total 
protein extracted from MSCs, as previously described20. The blots were probed with antibodies, made 
into rabbit, directed against mTOR, raptor (Cell Signaling, Izasa, Madrid, ES), vimentin, superoxide 
dismutase (SOD-2), lamin A/C and tubulin (all form Sigma-Aldrich) was used for housekeeping. A sec-
ondary anti-goat antibody (Cell Signaling) was used to visualize proteins using an AmershamTM ECLTM 
Western Blotting Analysis System (GE Healthcare, Amersham Biotechnology, Manchester, UK). Ideal 
concentrations for each antibody were determined empirically. Working concentrations were 1:1000 of 
the recommended stock solutions.
iTRAQ labelling. Equal amounts of proteins from each group of different age cells (100 μ g) were dena-
tured with 2% sodium dodecyl sulfate (SDS) in 1 M tryethylammonium bicarbonate (TEAB) (ABSciex, 
Foster City, CA). The samples were then reduced for 1 h at 60 °C using 50 mM tris-(2-carboxyethy) phos-
phine (TCEP) (ABSciex), and cysteine-blocked with 84 mM iodoacetamide (Sigma-Aldrich) at room 
temperature in the dark for 30 min. The proteins were digested with spectrometry grade trypsin (Gold 
Mass, Promega, Madison,WI) at a concentration of 1:50 trypsin/protein for 16 h at 37 °C. Each peptide 
Gene Name Fw primer Rv primer mRNA ID A.T. (°C)
Rex1 gtgcatcacacctcagactgt cgttggttgaaggccaactg NM_005106.4 61
Oct4 ctcctggagggccaggaatc atatacacaggccgatgtgg NM_00510 61
Sox2 ctccgggacatgatcagc ggtagtgctgggacatgtgaa NM_001109181.1 61
Nanog atgcctcacacggagactgt aagtgggttgtttgcctttg NM_005103.4 61
Vinculin aggagaccttgcgaagacagg gcggttgccacttgtttag NM_001107248 61
HPRT agccgaccggttctgtcat agccgaccggttctgtca NM_012583.2 61
Table 1.  Specific primers for real-time reverse transcriptase-polymerase chain reaction (RT-PCR) 
amplification, listed with their annealing temperature (A.T.). Fw = forward; Rv = r e v er s e .
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solution was labeled for 1.5 h at room temperature using the iTRAQ reagents previously reconstituted in 
70 μ L of ethanol, following the manufacture Protocol (ABSciex). The samples were labeled with iTRAQ 
reagents as follows: newborn: 119 and 121 as a control infant: 114; young: 116; pre-pubertal: 118; puber-
tal: 115; adult: 117. The reaction was stopped by adding deionized water, and the labeled samples were 
combined. The mixture was desalted using home-made stage-tips.
iTRAQ relative quantification by 2D-LC-MALDI-TOF/TOF analysis. In a first step, the desalted 
peptides were fractionated by basic reversed phase extraction in a 1400 HPLC system (Agilent). The 
fractions were collected along a 110 minutes gradient and subjected to further acidic reversed phase 
extraction in a nanoHPLC system (Tempo, ABSciex) into a C18 silica-based column (New Objective, 
Woburn, MA) with an internal diameter of 300 Ả. The injection volume was 5 μ L, and peptides were 
eluted during a ninety minutes gradient at a constant flow rate of 0.35 μ L/min. Eluting peptides were 
automatically mixed with alpha-cyano at 4 mg/mL en 70% AcN, TFA 0.1% and deposited on a MALDI 
LC-plate using a SunCollect (SunChrom) spotter. The chromatograms, composed by 350 spots, each one 
comprising a 15 sec deposition, were then analyzed in a 4800 MALDI-TOF/TOF platform (ABSciex). 
4000 series Explorer v.4.2 software was used to generate the spectra and peak list. After manual depo-
sition of mass calibrates, plate model and default calibration of the MALDI plate was done with a laser 
voltage of 3200 kV and 1000 shots/spectrum. Samples were automatically analyzed in MS mode with 
a laser voltage of 3400 kV and 1500 shots/spectrum. Automated precursor selection was done using a 
Job-wide interpretation method (up to 12 precursors/fraction, Signal to Noise lower threshold = 50) 
excluding trypsin autolytic peptides and other background ions, with a laser voltage of 4200 and 2000 
shots/spectrum. CID collision energy range: medium. LC-MALDI-TOF/TOF data were analyzed using 
ProteinPilot 4.0 software (ABSciex). Protein Pilot Search parameters were as follows: Sample type: 
iTRAQ 8-plex; Cys-alkylation: iodoacetamide; Digestion: trypsin; ID focus: Biological modifications; 
Database: last SwissProt release; Species filtering: none; Search effort: Thorough ID and Detection Protein 
Threshold Unused ProtScore (Conf)> 1.3 (95.0%). Scoring model was defined by the Paragon algorithm. 
In the case of the high complexity samples, False Discovery Rate -FDR- was estimated in less than 1% 
by doing the searching in parallel against a decoy database using “PSPEP on” mode -data not shown-.
Bioinformatics. Biological functional analysis of different modulated proteins detected by iTRAQ 
quantification, were categorized according to their function, biological process and cellular component, 
using the String 9.0 software21. Proteins with statistically significant changes were identified by filtering 
according to these criteria: 1) they had to be present in two biological replicates; 2) changes between 
groups had to be statistically significant (P < 0.05); and 3) fold change had to be greater than 1.2 and 
lower than 0.8 (date do not shown) This approach allowed us to select 201 differentially expressed pro-
teins for further analysis.
Enzymatic Analysis. 5 × 105 cells from each group of different age were used for the assessment of 
enzyme activities. The cells were homogenized in 200 μ L of 250 mM sucrose(Sigma-Aldrich, St.Louis, 
MO), 50 mM HEPES (Sigma-Aldrich), 0,5 mM EDTA (Sigma Aldrich) and one tablet protease inhib-
itor cocktail (Roche, Mannheim, Germany ). Enzymes activities were determined using a SUNRISE 
spectrophotometer (TECAN, Mannedorf, Switzerland). Reaction rates of enzymes were determined by 
the increase or decrease in absorbance of NAD(P)H (Sigma-Aldrich, St.Louis, MO) at 340 nm at 37 °C. 
Lactate dehydrogenise (EC 1.1.1.27) was determined in BM-MSCs using 50 mM Trizma base (pH 7,4), 
0,15 mM NADH and 5 mM sodium pyruvate (omitted for control) (all Sigma Aldrich, St.Louis, MO). 
Glucose-6-phosphate 1-deshydrogenase (EC 1.1.1.49) and 6-phosphogluconate dehydrogenase, decar-
boxylating (EC 1.1.1.343) was determined in BM-MSCs using 78 mM Trizma base, 5 mM MgCl2(pH 
7,4), 0,1 mM NADP, 0,5 mM D-Glucose 6-phosphate disodium salt hydrate and 6-Phosphogluconic acid 
trisodium salt (omitted for control) ( all Sigma-Aldrich, St.Louis, MO).
Statistics. All experiments were performed in triplicate and one representative is shown. 
Non-parametric statistical analyses were performed by Mann-Whitney-U and Kruskal-Wallis tests using 
GraphPad Prism6 (GraphPad Software, La Jolla, CA). Each group was compared with previous group. A 
p value less than 0.05 or 0.01 were considered statistically significant. All the the data are presented as 
standard error of the mean.
Results
Characterization of populations of MSCs from different ageing group by flow cytometry reveled that no 
statistical significant differences exist between group respects levels of mesenchymal and hematopoietic 
markers used for that (Fig. 1A). Positive cells for CD45 and CD34 were less than 1%, positive cells for 
CD29 were 30 ± 5% and positive cells for CD90 were 75 ± 5% in all groups studied.
Proliferation Assays results indicated that MSCs from groups of newborn (17 × 103 ± 100), young 
(21 × 103 ± 200), pubertal (15 × 103 ± 300) and adult (16 × 103 ± 100) animals had a statistically sig-
nificant higher (p < 0.01) number the cells compared to infant (9 × 103 ± 500), and pre-pubertal 
(10 × 103 ± 500) (Fig. 1B).
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Flow cytometry assays to detect CD117 and Ki67 positive cells indicated that MSCs from pubertal and 
young groups had the statistical significant (p < 0.01 and p < 0.05 respectively)) higher CD117 positive 
cells percentage of MSCs (74.65 ± 0.07 and 71.95 ± 3.10 respectively) than the rest of the groups studied, 
newborn: 61.53 ± 0.37; infant: 60.50 ± 1.58; adult: 61.12 ± 6.35 and pre-pubertal: 35.25 ± 2.14. On the 
other hand, infant and pre-pubertal groups had the statistical significant (p < 0.05) lower Ki67 positive 
cells percentage (15.63 ± 0.24 and 14.65 ± 0.41 respectively) than the rest of the groups studied, newborn: 
18 ± 0.55; young: 19.33 ± 0.43; pubertal 22.68 ± 0.40 and adult: 29.02 ± 0.16 (Fig. 1C)
Differentiation capacity of the groups studied was tested through direct mesoderm induction using 
specific culture medium. It was observed that pre-pubertal group presented statistically significant 
(p < 0.05) highest stain for safranine O, modified Masson´s and oil red by histological analysis followed 
by pubertal with respect to the other groups. Young group presented the highest staining, statistically 
significant (p < 0.05) for alizarin red with respect to others groups and the adult group presented the 
lowest statistically significant (p < 0.05) differentiation potential with respect to other groups (Fig. 2A,B). 
Nanog, Oct4, Sox2 and Rex1 gene expression were tested by qRT-PCR analysis to check the pluripotency 
potential of the studied groups. The results shown the statistically significant (p < 0.05) highest expres-
sion of Nanog in young group with respect to the others groups in opposition of statistically significant 
(p < 0.01) decrease expression of this same gene, Nanog, in the pre-pubertal group respect to the others 
(Fig. 2C).
All proteins from MSCs of rat bone marrow at different ages studied were compared between them. 
Summary each group was composed of a pool from 6 animals and two different iTRAQ experiments were 
performed. The results obtained in the iTRAQ study indicated that 1.072 proteins were identified, 201 of 
Figure 1. Proliferation profile from rat mesenchymal stem cells at different age. (A) Characterization 
by flow cytometry assay of percentage of positives mesenchymal stem cells markers (CD29 and CD73) 
and negative hematopoietic markers (CD34 and CD45). (B) Proliferation assay of studied aging groups 
for 6 days. (C) Percentage of proliferation markers, DC117 and Ki67, from studied aging groups by flow 
cytometry assay. One representative experiment is shown. #p value less than 0.05 compared with previous 
group and *p value less than 0.01 compared with previous group, were considered statistically significant 
using Mann-Whitney-U tests.
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Figure 2. Pluripotency profile from rats mesenchymal stem cells at different age. (A) Representative 
pictures of mesenchymal stem cell from bone marrow of studied age group after 14 days with specific 
differentiation medium. On the top specific medium is indicated; OS= osteogenic medium; AD = adipogenic 
medium; CH = chondrogenic medium. Differentiation medium are indicated in Material and methods. On the 
bottom stain is indicated; Ar = alizarin red; Or = oil red; Saf O = safranine O and MM = Modified Masson’s 
stain. Straight size is 200 μ M. (B) Densitometry study of mesenchymal stem cell from bone marrow of studied 
aging group after 14 days with specific differentiation medium after immunostaining assay. AnalySIS Image 
Processing computer was used to quantify the signal of different stain obtained. #p value less than 0.01 was 
considered statistically significant using Mann-Whitney-U tests. (C) Histogram represents gene expression of 
pluripotency markers, Rex1, Nanog, Sox2 and Oct4. Real-time reverse transcriptase PCR (qRT-PCR) analysis 
normalized by expression of HPRT gene used as housekeeping. #p value less than 0.01 compared with previous 
group was considered statistically significant using Mann-Whitney-U tests. Three replicates were made.
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them statistically significant modulated between groups (Table 2). These proteins have been grouped by 
three processes attending String 9.0 software; those groups were proliferation (60 proteins), pluripotency 
(86 proteins) and energy metabolism (55 proteins) (Table 2). Significant activates pathways obtained by 
comparing modulated proteins obtained by iTRAQ analysis employing functional annotations according 
to the String 9.0 software and classified in three biological process for better comprehension were shown 
in Fig. 3. A. Several proteins found in our analysis associated with proliferation were 60Sribosomal pro-
teins with different sedimentation speed like 60S RP L10, 60S RP L9, 60S RP L23, 60S RP L24, 60S RP 
L4, 60S RP L6 and 60S RP L7; also Vinculin which gene expression was validated by qRT-PCR analysis 
(Fig. 3D), all of them were statistically significant (p < 0.05) higher in newborn and adults with respect 
to the others groups. Superoxide dismutase-2 (SOD2) and Lamin A were increasing through the increas-
ing age group like occurred in the iTRAQ analysis; all of them were validated by western blot (Fig. 3B). 
Mitosox and total ROS were studied by flow cytometry to explain SOD2 results in our iTRAQ study, ROS 
and mitosox were statistically significant (p < 0.05) lower in infant and pre-pubertal groups with respect 
to the others groups respectively (Fig. 4A,B). A fluorescence-based assay to detect functional mitochon-
dria indicated that adult group had their functional mitochondria statistically significant decreased with 
respect to others groups of study (Fig. 5B). Proteins found in our iTRAQ analysis were associated with 
pluripotency like histones H1.5; H2B; H4 and protein disulfide-isomerase A1 (PDIA1) which were sta-
tistically significant (p < 0.05) high-regulated in infant and pubertal groups with respect to the others 
(Table 2). Several proteins found in our iTRAQ analysis associated whit energy metabolism were lactate 
dehydrogenase (LDH), glucose 6 phosphate dehydrogenase (G6PDH) and 6-phosphogluconate dehydro-
genase (6PGDH), which were validated through analysis of their activity by enzimoimmunoassay (GPI). 
Lactate dehydrogenase (LDH) activity was increased in young group in front to infant and newborn 
group, decreased in pre-pubertal group in a statistically significant way (p < 0.01) and come back to 
increase its activity in pubertal and adult groups (Fig. 4C), glucose 6 phosphate dehydrogenase (G6PDH) 
and 6-phosphogluconate dehydrogenase (6PGDH) were statistically significant increased (p < 0.01) in 
pubertal and adult groups in front to others (Fig. 4D).
Immunoblot analysis indicated that mTOR and Raptor were statistically significant (p < 0.05) lower 
in pre-pubertal and pubertal groups with respect to the other groups studied. Adult group presented the 
statistically significant (p < 0.05) most increased level of mTOR and Raptor (Fig.  5A), the permanent 
dye TMRM analysis indicated a decrease in functional mitochondria which was statistically significant 
(p < 0.01) in infant and adult groups with respect to newborn and pubertal groups respectively (Fig. 5B). 
Viability assay using two physiological concentrations of Imatinib mesylate or JK184 did not affect the 
cells in culture (Fig.  5C). JK184 decreased statistically significant (p < 0.01) the expression of KI67 at 
1mg/ml dose in culture (Fig.  5D). mTOR decreased dramatically in adult group when the cells were 
incubated with Imatinib mesylate or JK184 (Fig. 5E).
Discussion
It is good known that long-term in vitro culture, but not chronological aging, alters their morphology, 
susceptibility to senescence and mitochondrial function. Thus, independent from donor animal age, 
in vitro aging of MSCs seems to result in complete loss of their progenitor characteristics9. Accordingly, 
functional analysis demonstrated altered mitochondrial morphology, decreased antioxidant capacities 
and elevated ROS levels in long-term cultivated independently the aged of the donor. Our present study 
is limited to the usage of rat MSCs instead can be able to apply on human MSCs; it provides direct 
comparison between chronological aged MSC not only at the cellular but also at the molecular level.
MSCs populations from different ageing groups were characterized by flow cytometry to check per-
centage of positive cells for mesenchymal markers, CD29 and CD90, and to check that were negative 
for hematopoietic markers (CD34, CD45) (Fig. 1A). We did not observe statistical significant differences 
between the mesenchymal markers into the different MSCs aging group studied (Fig.  2C). These were 
coincident with results published by Jin et al.6 indicating that MSCs have similar levels of surface anti-
gen expression included MSCs from different tissues. Although the mesenchymal markers were not as 
abundant as published by Harting et al.22 these cells were able to adhere to the plastic plate and this is an 
intrinsic characteristic of mesenchymal stem cells and all of the groups were able to differentiate towards 
several mesoderm lineages (Fig. 2A,B). iTRAQ analysis is an adequate technique to study complex sam-
ples like we have used in this work23. Our results by iTRAQ analysis allowed the identification of 1.072 
proteins. 201 of them were statistically significant modulated between groups (Table 2). Our study rep-
resents a step further from a previous iTRAQ-based study24 where 156 differentially expressed proteins 
were detected. Furthermore we compared six chronologically different groups, giving more strength to 
our study. To generate the quantitative proteome using iTRAQ labeling, it was first determined the labe-
ling efficiency, which exceeded 99% (data not shown). Next, the cut-off for significant fold-change was 
determined based on the 2 biological replicates of two iTRAQ experiments which were chosen based 
on the following criteria: it contained more than 3 unique peptides (> 95%) and p value < 0.05 for the 
114/119 reporter ions. Accordingly, 90% of the commonly observed in the biological replicates fell within 
25% of the respective experimental variation (Data don´t shown). The fold-change thresholds of > 1.20 
or < 0.80 was set to identify true differences between expression of reporter ions.
One of the aims of our study was to establish the differences into proliferation process relating them 
to chronological donor age. Our results indicated that chronological age is directly influencing the 
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Accession Name Peptides (95%) I/N PVal I/N Y/I PVal Y/I PP/Y Pval PP/Y P/PP PVal P/PP A/P PVal A/P
Metabolism
 Q6P783 6-phosphofruc-tokinase 5 0,7228 0,1496 1,0497 0,7085 1,1027 0,3079 1,4117 0,0388 1,2082 0,2192
 Q7TP11
6-phospho-
gluconate 
dehydrogenase, 
decarboxylating
5 0,8664 0,0404 0,9404 0,345 1,1936 0,1035 1,2877 0,0026 0,6857 0,0099
 P06761
78 kDa glu-
cose-regulated 
protein
35 0,9172 0,0089 0,9677 0,334 1,1997 0 0,8295 0,002 1,4611 0
 M0RDC5
Acyl-CoA-
binding protein 
(Fragment)
1 0,9923 0,9393 1,0172 0,8471 1,0129 0,8865 1,1744 0,4947 1,408 0,0299
 F1LN88
Aldehyde 
dehydrogenase, 
mitochondrial
9 0,915 0,2981 0,9521 0,605 1,0255 0,8092 0,8105 0,1287 1,249 0,0303
 P07943 Aldose reduc-tase 9 1,0984 0,3717 0,8893 0,186 0,9549 0,5728 0,9715 0,7164 1,2055 0,0389
 Q91W30
Aldose 
reductase-like 
protein
10 1,6948 0,0054 0,5021 0,0183 1,2079 0,2492 1,0106 0,9424 1,2476 0,0229
 D3ZUM4 Beta-galacto-sidase 5 1,0315 0,7835 1,3171 0,0441 1,0942 0,385 1,1471 0,1506 0,9005 0,1892
 O35567
Bifunctional 
purine biosyn-
thesis protein 
PURH
13 0,9914 0,9389 0,8798 0,2663 1,1514 0,3918 0,8194 0,0166 1,1312 0,0362
 Q99JD5
Branched-
chain-ami-
no-acid ami-
notransferase
5 1,0463 0,7187 0,842 0,0756 1,3485 0,0127 0,9146 0,4169 0,9297 0,5047
 P15791
Calcium/
calmodulin-de-
pendent protein 
kinase type II 
subunit delta
5 0,9646 0,825 0,9676 0,8106 1,3814 0,0071 0,7966 0,044 1,0233 0,8049
 G3V9E3 Caldesmon 1, isoform CRA_b 18 1,0648 0,1599 0,9241 0,1919 1,4728 0 0,7388 0,0002 1,6353 0
 Q08290 Calponin-1 9 0,8714 0,0531 1,3003 0,0464 0,8214 0,2876 0,723 0,0013 1,2572 0,0412
 P37397 Calponin-3 10 1,3337 0,0378 0,8281 0,0224 1,0857 0,2275 0,7288 0,0035 1,1632 0,1397
 P18418 Calreticulin 12 1,1514 0,0446 0,8607 0,0394 1,3403 0,0004 0,7119 0,0002 1,4109 0,0004
 G3V6S3 Calumenin 5 1,0591 0,4369 1,0768 0,3271 0,9833 0,8456 0,7673 0,2524 1,5598 0,0141
 Q6P6T6 Cathepsin D 7 0,8801 0,1287 1,0622 0,3991 1,5419 0,0105 0,9111 0,1808 1,3326 0,0234
 P97601 Chaperonin 10 3 1,0204 0,7796 1,0011 0,9902 0,9415 0,5177 0,939 0,4419 1,4235 0,0087
 G3V936 Citrate synthase 3 0,7934 0,0267 1,167 0,0848 0,7904 0,0267 1,1452 0,2405 0,857 0,2318
 F1M779 Clathrin heavy chain 9 1,2157 0,0137 1 0,9994 0,9612 0,7295 1,1343 0,2338 0,8853 0,3235
 Q6TUH9
Corticosteroid 
11-beta-de-
hydrogenase 
isozyme 1
3 0,7341 0,2686 1,3756 0,2277 1,6421 0,0328 1,9857 0,0672 0,7338 0,0642
 P47875
Cysteine and 
glycine-rich 
protein 1
7 1,0015 0,9815 1,0448 0,5131 1,2576 0,0488 0,6896 0,0389 1,2501 0,0705
 O08651
D-3-phos-
phoglycerate 
dehydrogenase
3 0,8786 0,1902 0,7465 0,0308 1,1981 0,1105 1,1565 0,1448 1,0565 0,5069
 Q5BJ93 Enolase 1, (Alpha) 23 1,0226 0,655 1,026 0,5722 1,054 0,2406 0,7412 0 1,2752 0,0123
 Q8R4A1 ERO1-like protein alpha 5 0,8236 0,0936 1,0042 0,9607 1,1541 0,1632 1,0604 0,6296 1,4685 0,0439
 P05065
Fructose-bi-
sphosphate 
aldolase A
7 0,7852 0,0001 0,9961 0,9275 1,1519 0,0055 1,17 0,0228 1,1494 0,0589
Continued
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Accession Name Peptides (95%) I/N PVal I/N Y/I PVal Y/I PP/Y Pval PP/Y P/PP PVal P/PP A/P PVal A/P
 P11762 Galectin-1 13 0,8947 0,1869 1,0817 0,3224 0,9378 0,4491 0,738 0,0127 1,2891 0,0226
 Q8CJG5 Gene 3 0,9562 0,7992 0,6552 0,233 1,5338 0,0488 1,0942 0,6762 0,9227 0,7939
 P05370
Glu-
cose-6-phos-
phate 1-dehy-
drogenase
16 1,0157 0,847 1,0285 0,7414 0,9947 0,9314 1,0827 0,1708 1,2136 0,0003
 Q6P6V0
Glu-
cose-6-phos-
phate isomerase
13 0,859 0,1021 0,9669 0,5321 1,1179 0,0929 1,1489 0,1394 1,2446 0,0072
 P04797
Glyceralde-
hyde-3-phos-
phate dehydro-
genase
28 1,0559 0,3012 1,2268 0,0077 0,8176 0,0404 1,0972 0,4988 0,8495 0,1048
 P56574
Isocitrate 
dehydrogenase 
[NADP], mito-
chondrial
3 1,0223 0,8926 1,0131 0,8828 0,8721 0,3389 1,3609 0,025 0,8545 0,1231
 B5DEN4 L-lactate dehy-drogenase 14 0,7058 0,0001 1.146 0,00197 1.1828 0,0191 1.2617 0 1.416 0
 Q6P7A9
Lysosomal 
alpha-gluco-
sidase
4 0,9754 0,7869 1,0694 0,6226 1,4268 0,048 0,8687 0,254 1 1
 Q6AYC4
Mac-
rophage-cap-
ping protein
2 1,1578 0,3404 1,3646 0,0086 0,8334 0,049 0,7546 0,0948 1,3655 0,0617
 F1LP60 Moesin (Frag-ment) 40 1,0168 0,6741 0,8227 0,0003 1,4257 0 0,9895 0,8299 0,9461 0,1782
 P20070
NADH-cy-
tochrome b5 
reductase 3
2 0,7339 0,0716 1,4911 0,0447 0,9088 0,5256 0,9743 0,903 0,8315 0,169
 Q6XD99 Non-erythroid spectrin beta 2 1,3375 0,0053 1,0624 0,4554 1,1109 0,3101 0,7568 0,0122 1,5134 0,0041
 P16617 Phosphoglycer-ate kinase 1 29 0,775 0 1,0397 0,3579 1,0241 0,6829 1,1179 0,0446 1,3076 0
 P25113 Phosphoglycer-ate mutase 1 9 0,7559 0,0052 1,1081 0,1211 1,1188 0,142 1,105 0,1848 1,3205 0,0024
 P54001
Prolyl 4-hy-
droxylase subu-
nit alpha-1
15 0,9432 0,3007 0,923 0,1417 1,26 0,0005 0,779 0,0002 0,9234 0,2253
 M0R9D5 Protein Ahnak 60 1,4134 0 0,9734 0,2788 1,2761 0 0,8082 0 2,1551 0
 D3ZIE9 Protein Ald-h18a1 5 1,2134 0,1403 1,038 0,7002 0,5751 0,0236 0,8643 0,2248 0,7301 0,0622
 M0R3 × 6 Protein LOC100912203 6 0,8645 0,163 1,0325 0,6321 1,1276 0,2248 0,9918 0,9068 1,2992 0,0104
 D4A5L9 Protein LOC679794 4 0,6761 0,0039 1,6157 0,0178 0,7517 0,0082 0,9865 0,8661 1,0755 0,375
 Q6P9U0 Protein Ser-pinb6 8 0,9886 0,8679 1,0239 0,6691 1,3013 0,0066 0,8823 0,2774 1,1196 0,16
 D3ZF39 Protein Uap1 10 1,0277 0,7709 1,0072 0,947 1,6544 0,0038 0,9744 0,7756 1,6238 0,0005
 B0BMT0 RCG47746, iso-form CRA_a 90 1,0669 0,6161 0,7141 0,0061 1,4858 0,0047 0,5813 0,0012 0,7691 0,1418
 Q6IRL3 Reticulon 7 1,0111 0,8671 0,8818 0,3109 1,3224 0,0677 0,7406 0,0052 0,9133 0,4439
 B2GVB1
S100 calcium 
binding protein 
A6
3 1,0605 0,5609 1,2045 0,2186 1,7118 0,0122 0,3918 0,0244 1,665 0,037
 Q5U3Z7
Serine hydrox-
ymethyltrans-
ferase
3 0,7739 0,0051 0,9472 0,5152 1,0085 0,9511 1,1442 0,2328 1,0402 0,831
 F1M953
Stress-70 
protein, mito-
chondrial
12 0,9377 0,2437 0,7924 0,0057 1,174 0,0025 0,8961 0,1199 1,5666 0
 P48500 Triosephos-phate isomerase 16 0,6753 0,0004 1,174 0,0315 1,0854 0,3958 1,2639 0,1091 1,4017 0,0001
 Q9Z1A6 Vigilin 3 1,1784 0,0874 0,8426 0,0918 1,0244 0,862 0,9978 0,9727 1,2104 0,0345
Continued
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Accession Name Peptides (95%) I/N PVal I/N Y/I PVal Y/I PP/Y Pval PP/Y P/PP PVal P/PP A/P PVal A/P
 P81155
Voltage-de-
pendent 
anion-selective 
channel pro-
tein 2
6 1,0012 0,9931 1,0633 0,4458 1,2708 0,0343 0,8377 0,1616 0,992 0,9444
Pluripotency
 P63102 14-3-3 protein zeta/delta 24 0,9971 0,9573 0,9743 0,6297 1,0748 0,2065 0,8947 0,1104 1,1562 0,0250
 Q7TP91 Ab1-205 3 0,9802 0,8434 1,2607 0,1387 0,9026 0,3795 1,0629 0,7975 0,6232 0,0302
 Q64640 Adenosine kinase 2 0,9609 0,8197 1,1207 0,3134 1,1155 0,346 1,0828 0,4536 0,6855 0,0454
 P39069
Adenylate 
kinase isoen-
zyme 1
4 0,7781 0,0775 1,2606 0,053 1,0747 0,7679 0,9795 0,8759 1,6777 0,029
 P23928 Alpha-crystallin B chain 5 1,207 0,0573 1,8689 0,0119 2,2257 0,0003 0,2931 0,0035 1,5629 0,0723
 Q6IMZ3 Annexin A6 24 1,2484 0,0001 1,1079 0,0199 0,9791 0,5623 1,0031 0,9354 1,0187 0,5863
 Q07936 Annexin A2 22 1,2928 0 1,0234 0,6825 1,368 0,0001 0,8172 0,003 1,072 0,1567
 Q05175 Brain acid solu-ble protein 1 3 0,9481 0,8617 1,209 0,454 1,3727 0,148 0,4584 0,0445 1,6462 0,1009
 Q6T487
Brain-specific 
alpha actinin 1 
isoform
48 0,7786 0,0007 1,1584 0,0465 1,0249 0,6506 0,8259 0,0018 1,1052 0,2188
 Q8R4A2 Caveolin 1 (Fragment) 4 0,9676 0,8582 1,8465 0,0328 1,0661 0,7396 0,7326 0,1573 1,0726 0,6061
 P02454 Collagen al-pha-1(I) chain 21 1,9314 0,0008 0,4642 0 1,3783 0 1,1251 0,0342 1,123 0,1023
 F1LS40 Collagen al-pha-2(I) chain 19 1,486 0,0008 0,6971 0 1,1467 0,0083 0,9555 0,2908 1,3211 0,0003
 P07335 Creatine kinase B-type 3 0,7036 0,0109 1,1785 0,2497 1,4259 0,0546 0,8379 0,2386 1,2443 0,3604
 F1LMA7 C-type man-nose receptor 2 5 1,1259 0,191 0,8731 0,3184 0,8322 0,3836 0,8408 0,3689 1,7697 0,0009
 P47875
Cysteine and 
glycine-rich 
protein 1
5 1,0995 0,2349 0,9264 0,4028 1,275 0,0227 0,7329 0,0396 1,2025 0,1773
 Q6AYI1
DEAD (Asp-
Glu-Ala-Asp) 
box polypep-
tide 5
9 0,9335 0,2865 0,9937 0,9257 0,8965 0,0659 1,2504 0,0032 0,9596 0,434
 Q62952
Dihydropy-
rimidinase-re-
lated protein 3
8 1,2443 0,0364 1,5656 0,0028 0,858 0,2853 0,8247 0,0165 1,0088 0,9184
 Q4V8H8
EH do-
main-contain-
ing protein 2
0 0,9656 0,7399 1,3396 0,2041 0,8004 0,248 1,6703 0,0471 0,7495 0,491
 Q68FR6 Elongation fac-tor 1-gamma 9 1,0087 0,8562 0,9072 0,4157 1,2134 0,0011 0,9535 0,5667 0,8485 0,0109
 C0JPT7 Filamin alpha 100 1,2134 0 1,3022 0 0,8202 0 0,9147 0,0068 1,386 0
 D4A8D5 Filamin, beta (Predicted) 19 1,0951 0,0867 1,2541 0,0012 0,8193 0,0061 0,7937 0,0124 1,329 0,0009
 B6DYQ7 Glutathione S-transferase pi 4 1,0946 0,3206 1,1008 0,6055 1,5111 0,0241 3,1507 0,0004 0,3406 0,0033
 G3V913
Heat shock 
27kDa pro-
tein 1
5 1,6407 0,0562 0,9647 0,8462 1,5674 0,0118 0,636 0,038 1,3145 0,0077
 P63018
Heat shock 
cognate 71 kDa 
protein
30 0,9815 0,6625 1,2334 0,0221 0,8841 0,0143 1,0164 0,8526 1,1903 0,0184
 F1M3D3
Heterogeneous 
nuclear ribonu-
cleoprotein M
3 0,6983 0,0017 1,0334 0,5966 0,9158 0,4502 1,1725 0,1239 1,0388 0,7714
Continued
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 Q6IMY8
Heterogeneous 
nuclear ribonu-
cleoprotein U
8 0,7965 0,0032 1,0228 0,7409 0,9994 0,9956 1,1924 0,0262 0,8534 0,1414
 P15865 Histone H1.4 8 0,7411 0,0048 2,4013 0,0005 1,0711 0,2301 0,5016 0,0007 0,6377 0,007
 D3ZBN0 Histone H1.5 4 1,911 0,0166 0,4907 0,0135 0,9905 0,9189 1,4031 0,0552 0,8838 0,2767
 G3V9C7 Histone H2B 20 1,2535 0,0051 0,9957 0,9764 0,8311 0,1792 1,4957 0,0005 0,7706 0,0027
 M0RBX6 Histone H3 6 1,1323 0,058 1,4413 0,0125 1,201 0,0272 0,5991 0,0004 0,494 0,0002
 P62804 Histone H4 13 1,4819 0,0057 0,5999 0,0004 1,1515 0,0641 1,7155 0,0008 0,6785 0,002
 Q6P6G9 Hnrpa1 protein 8 0,6091 0,0304 0,9626 0,6587 0,943 0,663 1,1142 0,7189 0,969 0,7865
 P50503 Hsc70-interact-ing protein 4 0,9785 0,7614 1,0509 0,7519 1,1426 0,4415 0,8392 0,2581 1,5699 0,0074
 P49134 Integrin beta-1 6 1,5471 0,0002 0,9023 0,1179 1,5398 0,0098 0,7217 0,0064 1,311 0,0037
 G3V7Q7
IQ motif con-
taining GTPase 
activating 
protein 1 (Pre-
dicted), isoform 
CRA_b
29 0,9058 0,0331 0,8665 0,0016 1,2223 0 1,0398 0,2744 0,8961 0,0032
 Q6TXE9 LRRGT00050 4 0,8206 0,0425 0,8878 0,4999 1,0972 0,6832 1,5 0,0036 0,8044 0,129
 Q6TUD1 LRRGT00113 2 0,7362 0,0289 1,0159 0,9238 1,0387 0,7991 1,0836 0,5779 0,9606 0,8364
 Q5M7W5
Microtu-
bule-associated 
protein 4
2 1,6111 0,1601 0,845 0,5023 1,0907 0,433 0,6693 0,1236 1,6243 0,0414
 B2GV99 Myl6 protein 11 1,0049 0,9535 1,1269 0,1948 1,0655 0,29 0,9193 0,1676 1,3394 0,0011
 G3V9Y1
Myosin, heavy 
polypeptide 10, 
non-muscle, 
isoform CRA_b
51 0,9356 0,0771 1,0793 0,1827 0,8786 0,0186 0,8988 0,0205 0,792 0,0018
 G3V6P7
Myosin, heavy 
polypeptide 9, 
non-muscle
98 0,9405 0,0071 1,1877 0 1,0117 0,6464 0,957 0,2338 1,3299 0
 P05982
NAD(P)H 
dehydrogenase 
[quinone] 1
8 1,3454 0,0036 0,7746 0,0108 1,2457 0,0611 0,817 0,2198 1,7303 0,0017
 G3V8R1 Nucleobindin 2, isoform CRA_b 3 0,7234 0,0259 2,0743 0,0023 0,5945 0,0061 0,8133 0,1039 1,5101 0,0176
 F1M4W3 Palladin (Frag-ment) 6 1,0033 0,9633 0,8726 0,1096 1,0418 0,6509 0,6823 0,0117 1,0929 0,2707
 P52944
PDZ and 
LIM domain 
protein 1
8 1,0741 0,3026 1,0802 0,1599 1,3743 0,0005 0,9648 0,7456 1,2349 0,03
 Q62920
PDZ and 
LIM domain 
protein 5
17 0,9467 0,5156 0,6947 0,0022 1,4784 0,0057 0,6885 0,0358 0,8014 0,071
 Q6AYQ9
Peptidyl-pro-
lyl cis-trans 
isomerase
6 0,9218 0,2069 0,9782 0,6989 1,2033 0,0649 0,7408 0,0209 0,837 0,0475
 Q62658
Peptidyl-pro-
lyl cis-trans 
isomerase 
FKBP1A
2 1,254 0,0638 1,1087 0,2151 1,0291 0,6981 0,8516 0,0786 1,38 0,0149
 D3ZAF5
Periostin, oste-
oblast specific 
factor (Predict-
ed), isoform 
CRA_a
4 0,5315 0,1266 1,4489 0,0583 0,7663 0,0352 1,3251 0,0507 0,8907 0,4068
 Q63716 Peroxiredoxin-1 13 0,8935 0,0404 1,0622 0,5224 1,083 0,5586 0,884 0,3841 1,2919 0,0335
 P35704 Peroxiredoxin-2 5 0,9438 0,6729 1,3399 0,0331 0,9268 0,3898 0,8375 0,2252 1,1003 0,4352
 Q9R063
Peroxiredox-
in-5, mitochon-
drial
5 1,0571 0,6808 0,7826 0,0577 1,2214 0,0908 0,8798 0,195 1,4277 0,0498
 F1LPK7 Phospholipid scramblase 3 5 1,3539 0,015 0,7564 0,0206 1,2564 0,0285 0,9783 0,8008 1,0061 0,9704
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 G3V8L9
Polymerase I 
and transcript 
release factor
10 1,0181 0,7755 1,5741 0,0001 1,2442 0,0026 0,6574 0,0001 1,2032 0,1746
 G3V9I0
Procollagen-ly-
sine,2-ox-
oglutarate 
5-dioxygenase 2
15 0,6772 0,0001 1,3393 0,0139 0,8435 0,0459 1,1106 0,2824 1,033 0,765
 D3ZRX9 Protein Cnn2 9 0,9803 0,7232 0,9782 0,6955 1,1542 0,0382 0,7727 0,0037 1,1053 0,1116
 G3V6T7
Protein 
disulfide 
isomerase 
associated 4
4 1,094 0,3778 1,5291 0,0042 0,7583 0,087 0,8527 0,0368 1,1596 0,0466
 P04785
Protein di-
sulfide-isomer-
ase
18 0,9524 0,2161 0,9019 0,0205 1,1449 0,002 0,91 0,0672 1,3562 0
 P11598
Protein di-
sulfide-isomer-
ase A3
23 1,0044 0,9331 1,1813 0,0003 1,0096 0,899 0,888 0,1863 1,151 0,1114
 Q63081
Protein di-
sulfide-isomer-
ase A6
9 0,7832 0,0043 1,1044 0,262 1,2788 0,0234 0,9335 0,4195 1,0394 0,5727
 D3ZHA0 Protein Flnc 28 0,9537 0,2739 1,6131 0 0,8375 0,0128 0,9354 0,1802 1,1796 0,0125
 E2RUH2 Protein LOC100360501 3 0,8715 0,4837 1,2547 0,0379 0,7763 0,024 1,2418 0,1487 0,7978 0,0359
 M0R7B4 Protein LOC684828 6 1,9171 0,003 0,4959 0,0035 1,0813 0,3542 1,3227 0,0305 0,8447 0,1021
 F1MA29 Protein LOC685520 5 0,7506 0,0026 1,15 0,0892 0,9181 0,414 1,0561 0,438 1,066 0,4416
 D3ZUB0 Protein Rcn1 2 1,0185 0,8167 0,8941 0,2217 1,1262 0,2053 0,8607 0,297 1,3273 0,0313
 I6L9G5 Protein Rcn3 2 1,0873 0,4834 0,5646 0,023 1,147 0,2936 0,9716 0,7715 1,3833 0,2381
 D4A1P2 Protein Rpl10l 7 1,0101 0,8587 0,8912 0,0814 0,8855 0,0554 1,4153 0,0002 0,6894 0,0001
 F1M853 Protein Rrbp1 12 0,9865 0,8266 0,9487 0,2254 1,4058 0,0002 0,6416 0,0002 1,4396 0
 P05942 Protein S100-A4 8 1,3344 0,0883 0,8596 0,3432 2,371 0,0005 0,6816 0,0449 1,6256 0,0034
 B0BMT9 Protein Sqrdl 5 0,8772 0,1123 0,8745 0,2138 1,3482 0,0318 0,672 0,0272 1,1637 0,2917
 P50399
Rab GDP 
dissociation 
inhibitor beta
5 0,6527 0 1,1226 0,1842 0,8087 0,0191 1,2167 0,0909 0,8327 0,0497
 Q5FVG5
Similar to 
tropomyosin 
1, embryonic 
fibroblast-rat, 
isoform CRA_c
21 0,8189 0,0635 0,8236 0,0664 1,5332 0,0055 0,4284 0,0029 0,9622 0,622
 Q6IRH6 Slc25a3 protein 5 0,6221 0,0046 1,2418 0,0813 0,9018 0,3869 1,2937 0,0271 0,7334 0,0095
 P06685
Sodium/po-
tassium-trans-
porting ATPase 
subunit alpha-1
6 1,0612 0,5229 0,847 0,0206 0,9521 0,6531 1,1204 0,4092 0,8973 0,1495
 P16975 SPARC 5 1,2574 0,0585 0,8963 0,1879 1,0501 0,5303 0,9358 0,5629 1,2361 0,0437
 Q63413
Spliceosome 
RNA helicase 
Ddx39b
4 0,7567 0,0206 1,0276 0,7991 0,904 0,431 1,3219 0,0189 0,679 0,0523
 Q6IRK8 Spna2 protein 9 1,3867 0 1,211 0,003 1,0232 0,7136 0,7877 0,0016 1,7205 0
 D4A8Y5
Staphylococcal 
nuclease do-
main-contain-
ing protein 1
3 0,919 0,451 1,2908 0,0445 0,8256 0,0815 1,2376 0,0644 0,7802 0,1202
 Q71SA3 Thrombospon-din 1 7 0,8058 0,0398 0,7166 0,0007 1,3192 0,0007 0,9713 0,6767 1,4974 0,0023
 P31232 Transgelin 39 1,2096 0,0003 1,2967 0,0743 1,133 0,0136 0,5637 0,0001 1,7372 0
 Q5XFX0 Transgelin-2 17 0,9888 0,8414 1,0039 0,955 1,3666 0,0009 0,9786 0,7678 1,1396 0,048
 Q6AYT3
tRNA-splicing 
ligase RtcB 
homolog
4 0,6896 0,019 0,9867 0,8815 0,8815 0,1894 1,1372 0,1808 0,8525 0,4565
Continued
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Accession Name Peptides (95%) I/N PVal I/N Y/I PVal Y/I PP/Y Pval PP/Y P/PP PVal P/PP A/P PVal A/P
 Q63610 Tropomyosin alpha-3 chain 9 0,9843 0,838 1,4987 0,0199 1,2255 0,0709 0,6776 0,0538 1,8819 0,0153
 P09495 Tropomyosin alpha-4 chain 12 0,9739 0,7802 1,356 0,0682 1,0117 0,925 0,8335 0,1905 1,5771 0,0401
 G3V6C4
UDP-glucose 
6-dehydroge-
nase
8 1,0597 0,478 0,9444 0,6809 1,256 0,011 1,0009 0,9911 1,4008 0,0135
 Q63355 Unconventional myosin-Ic 10 1,2333 0,0007 0,8095 0,0071 1,2252 0,0431 1,0652 0,3451 0,8854 0,0253
 P31000 Vimentin 110 1,0703 0,0545 1,0991 0,0394 1,1756 0,0018 0,76 0 0,9955 0,9047
Proliferation
 P62268 40S ribosomal protein S23 3 1,0729 0,3955 0,7949 0,0312 1,0116 0,8769 0,9447 0,6609 1,0981 0,4568
 M0RD75
40S ribosomal 
protein S6 
(Fragment)
5 1,213 0,0348 0,7478 0,0343 1,0648 0,6105 0,8839 0,3222 1,2172 0,0637
 B2RYR8 40S ribosomal protein S8 5 1,156 0,0743 0,7651 0,0113 0,9563 0,6408 1,1034 0,3318 1,0474 0,6037
 P29314 40S ribosomal protein S9 10 1,2232 0,0078 0,7297 0,0002 1,1604 0,014 1,0442 0,4378 1,0231 0,6427
 P38983 40S ribosomal protein SA 7 1,0045 0,948 0,8267 0,0864 1,0707 0,3666 1,3083 0,0159 0,8177 0,0379
 P63039
60 kDa heat 
shock protein, 
mitochondrial
14 1,0284 0,7397 1,0424 0,6331 1,0209 0,827 0,7502 0,0126 1,1048 0,3793
 Q6PDV7 60S ribosomal protein L10 8 1,2944 0,0232 0,7476 0,0503 1,0811 0,4911 0,9186 0,3735 1,079 0,2893
 P41123 60S ribosomal protein L13 4 1,2788 0,1225 0,8351 0,0607 1,0613 0,7175 1,269 0,0179 0,8472 0,0781
 P61314 60S ribosomal protein L15 2 1,0608 0,6431 0,9332 0,5211 0,8939 0,228 1,6856 0,0065 0,7429 0,0338
 Q0QEW8
60S ribosomal 
protein L18 
(Fragment)
3 0,8899 0,3903 1,0505 0,6391 0,9184 0,5621 1,4963 0,0365 0,7225 0,0735
 P62718 60S ribosomal protein L18a 4 1,0118 0,8521 0,8707 0,2832 1,0157 0,9288 1,3147 0,032 0,8694 0,1711
 P62832 60S ribosomal protein L23 6 1,2256 0,0212 0,838 0,0334 0,9969 0,9615 0,9723 0,8064 1,1553 0,1309
 P83732 60S ribosomal protein L24 7 1,5524 0,0024 0,5064 0,0004 1,2108 0,0391 0,8698 0,2155 1,2834 0,0175
 P25886 60S ribosomal protein L29 3 1,5331 0,0443 0,9651 0,7362 1,0984 0,4167 0,8404 0,5923 0,7419 0,2733
 P21531 60S ribosomal protein L3 5 1,0552 0,6436 0,8494 0,0879 0,932 0,5476 1,463 0,0213 0,7223 0,0148
 Q6P3V9 60S ribosomal protein L4 9 1,419 0,0021 0,627 0,0002 1,0227 0,7849 0,9688 0,6057 1,139 0,0543
 P09895 60S ribosomal protein L5 6 0,9424 0,3628 0,9732 0,6933 0,9466 0,5073 1,2345 0,0225 0,8597 0,1305
 H7C5Y5 60S ribosomal protein L6 7 1,3496 0,0261 0,6716 0,0068 1,0461 0,66 1,0542 0,451 1,0501 0,6358
 Q6P790
60S ribosomal 
protein L6 
(Fragment)
7 1,2191 0,0025 1,0302 0,7281 1,0286 0,6572 0,8965 0,2512 0,987 0,8763
 P05426 60S ribosomal protein L7 5 1,3498 0,0462 0,6788 0,065 1,1405 0,3092 0,9309 0,3885 1,0532 0,5387
 P85970
Actin-related 
protein 2/3 
complex sub-
unit 2
11 0,9564 0,6557 0,9226 0,2715 1,3327 0,0061 1,0044 0,938 1,0774 0,3839
 Q9Z1P2 Alpha-actinin-1 77 0,8727 0,0028 0,8694 0,0002 1,3424 0,0013 0,8164 0,0001 0,9543 0,1358
 Q9QXQ0 Alpha-actinin-4 50 1,2074 0,0004 1,1204 0,037 1,0349 0,3567 0,9069 0,2105 1,1419 0,036
 Q66HH8 Annexin 5 9 0,9925 0,8998 1,0383 0,7603 0,9707 0,811 0,9909 0,8915 1,4149 0,0034
Continued
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Accession Name Peptides (95%) I/N PVal I/N Y/I PVal Y/I PP/Y Pval PP/Y P/PP PVal P/PP A/P PVal A/P
 P45592 Cofilin-1 12 1,2442 0,0041 1,0603 0,5475 1,0804 0,2025 0,9203 0,5481 1,2685 0,011
 D3ZH41
Cytoskele-
ton-associated 
protein 4 
(Predicted)
12 0,7853 0,0004 1,107 0,0513 0,9476 0,3458 0,7919 0,0005 1,2344 0,0033
 Q6AYH5 Dynactin subunit 2 3 1,151 0,2739 0,8845 0,3112 1,1661 0,2508 0,8114 0,3778 1,3787 0,0248
 P52555
Endoplasmic 
reticu-
lum  resident 
protein 29
2 1,0186 0,8459 1,3064 0,1141 1,2519 0,2488 0,8626 0,2226 1,5742 0,0319
 Q6P3V8
Eukaryotic 
translation 
initiation factor 
4A1
13 1,0465 0,4461 0,8673 0,0328 1,055 0,416 1,0269 0,6429 0,7893 0,0001
 P04937 Fibronectin 17 1,1267 0,3104 0,7887 0,0119 1,2538 0,0001 0,6481 0,0907 2,4985 0,0056
 Q6P792 Four and a half LIM domains 1 6 0,7431 0,0006 1,7903 0,0001 1,1108 0,096 0,7768 0,0085 0,8731 0,0375
 P11762
Galectin-1 
OS= Rattus 
norvegicus
14 0,7674 0,0204 0,7313 0,053 1,2804 0,0564 0,8213 0,4313 1,1116 0,227
 B6DYQ2
Glutathione 
S-transferase 
mu 2
5 1,1023 0,4484 1,0507 0,6202 0,8053 0,0678 0,8616 0,3082 1,2838 0,0235
 P63245
Guanine nucle-
otide-binding 
protein subunit 
beta-2-like 1
6 1,0188 0,7481 0,8543 0,044 1,0255 0,6962 1,0046 0,963 0,9843 0,8938
 Q6P7Q4 Lactoylglu-tathione lyase 6 0,8942 0,2376 0,9113 0,2336 1,2099 0,0449 0,9186 0,2639 1,0132 0,8509
 G3V8L3 Lamin A, iso-form CRA_b 26 0,9048 0,0029 0,968 0,4478 1,1812 0,0001 1,0126 0,746 1,2067 0
 Q99MZ8
LIM and SH3 
domain pro-
tein 1
5 1,4773 0,0032 1,0103 0,9316 1,1251 0,1144 0,7622 0,0071 1,3922 0,0031
 O08557
N(G), N(G)-di-
methylarginine 
dimethylamino-
hydrolase 1
4 0,8682 0,4556 2,2145 0,0173 0,5358 0,0395 0,7504 0,1763 1,2909 0,0453
 Q6S3A0 Plectin 6 28 1,0437 0,2665 0,9378 0,1139 1,1564 0,0026 0,996 0,9259 1,2269 0,0027
 D4A4Z9 Protein Ktn1 7 0,9773 0,8388 0,901 0,2289 1,3423 0,0487 0,7373 0,0131 1,0952 0,3487
 D3ZPL5 Protein LOC100361311 10 1,2843 0,0356 0,683 0,017 1,0148 0,8697 0,9663 0,7274 1,1144 0,0623
 M0RCY2 Protein LOC683961 6 0,9886 0,9133 0,9596 0,6555 0,761 0,0353 1,4335 0,0202 0,591 0,0003
 D3ZN21 Protein RGD1309586 6 0,951 0,6075 0,9746 0,7735 0,957 0,6381 1,2502 0,0226 0,8539 0,0205
 D4A6W6 Protein RGD1561333 6 1,7423 0,0038 0,5049 0,0038 1,2265 0,2464 0,8945 0,5405 1,1717 0,2285
 D4A6W6 Protein RGD1561333 5 1,1352 0,1387 1,0601 0,5478 0,9173 0,2914 1,5332 0,0034 0,6202 0,0124
 F1LT35
Protein 
RGD1564606 
(Fragment)
6 1,1172 0,1379 1,1037 0,4799 1,0681 0,4407 0,772 0,0124 1,2544 0,0157
 G3V852 Protein Tln1 38 1,2686 0 1,2229 0 0,8272 0 0,9642 0,3307 1,3768 0
 Q4QQV0 Protein Tubb6 22 1,0776 0,4062 0,8668 0,3417 1,2995 0,0298 0,946 0,6332 1,0638 0,6569
 Q6P3E1 Rps16 protein (Fragment) 7 1,6881 0,0047 0,5471 0,0061 1,508 0,0481 0,8378 0,1083 1,2384 0,0629
 Q9QZR6 Septin-9 6 1,0595 0,4348 0,9334 0,3019 1,2185 0,0277 0,8772 0,1483 1,017 0,8438
 Q6LDS4
Superoxide 
dismutase 
[Cu-Zn]
6 1,1464 0,0737 1,169 0,0483 0,8679 0,0643 1,0068 0,9549 1,3603 0,0094
Continued
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Accession Name Peptides (95%) I/N PVal I/N Y/I PVal Y/I PP/Y Pval PP/Y P/PP PVal P/PP A/P PVal A/P
 P07895
Superoxide dis-
mutase [Mn], 
mitochondrial
10 0,76 0,2573 0,9976 0,9829 2,2825 0,02 1,074 0,2946 1,3438 0,0046
 P28480
T-complex pro-
tein 1 subunit 
alpha
6 0,7782 0,0579 1,5251 0,0086 0,9731 0,7177 1,2381 0,2501 0,9675 0,8659
 Q68FQ0
T-complex pro-
tein 1 subunit 
epsilon
4 0,8933 0,2273 1,0047 0,9576 0,9601 0,7021 1,1826 0,1497 0,8175 0,0229
 Q6P502
T-complex pro-
tein 1 subunit 
gamma
5 1,0456 0,4189 0,8549 0,0333 1,0502 0,74 1,0936 0,3134 0,9009 0,3475
 P11232 Thioredoxin 9 0,9519 0,7004 0,9806 0,8828 1,1098 0,4942 0,9058 0,4438 1,2619 0,0373
 Q99PD6
Transforming 
growth factor 
beta-1-induced 
transcript 1 
protein
6 1,0858 0,7029 0,7535 0,8138 1,2703 0,2603 0,635 0,0115 0,8607 0,8969
 P68370
Tubulin 
alpha-1A chain 
OS= Rattus 
norvegicus 
GN= Tuba1a 
PE= 1 SV= 1
19 1,1996 0,0477 1,1154 0,0721 0,7776 0,0946 0,9411 0,7092 0,7696 0,0004
 R9PXU6 Vinculin 57 1,1908 0 0,9981 0,9534 1,4169 0 0,8383 0,0001 1,1453 0
Table 2.  List of modulated proteins in mesenchymal stem cells at different ages classified according to 
their principal biological process using iTRAQ analysis.
expression of proliferation marker Ki6725 because of the lowest levels of Ki67 corresponded with less 
cells number in proliferation assays in infant and pre-pubertal groups. On the other way high levels 
of CD117, a self-renewal marker in MSCs as indicated Blazquez-Martinez et al.26 were corresponding 
to higher cells number in proliferation assay of pubertal and adult groups of animal respect to the rest 
groups (Fig. 1B,C).
60 modulated proteins found in our iTRAQ analysis were involved in proliferation as 60S ribo-
somal proteins with different sedimentation speed like 60S RP L10, 60S RP L9, 60S RP L23, 60S 
RP L24, 60S RP L4, 60S RP L6 and 60S RP L7 were over-expressed in young group respect to the 
others indicating their increased potential of pluripotency which would be in concordance with its 
low expression of Nanog gene by RT-PCR analysis (Fig. 2C) in this group as also Das et al.27 found 
over-expressed these proteins in different animal model process. Our results indicated that expression 
of Vinculin gene (Fig.  3C) was very low in newborn and young which were the most proliferative 
groups (Fig.  1B) on the opposite way pre-pubertal and adult presented high Vinculin gene expres-
sion coincidently with less proliferative potential. Toma-Jonik et al.28 published very recently that 
Vinculin, which is a protein involved in cell motility and adherence, was down-regulated in cells 
with great mobilization and proliferation potential like melanoma cells and at the same time Piltti 
et al.29 published that Rho kinase inhibitor (ROCKi) treatment increased the cellular proliferation 
up, in human foreskin fibroblast cells and, significantly less Vinculin-associated focal adhesions were 
present in these ROCKi-treated cells30. 11β -hydroxysteroid dehydrogenase type 1 (11β -HSD1), is an 
enzyme which generates glucocorticoids in intact cells, was found in our iTRAQ analysis signifi-
cant increased in prepubertal group, this fact could explain the decrease proliferation potential and 
increase adypogenic differentiation in prepubertal group. All this is coincident with Bujalska et al.31 
who published that 11β -HSD1 activity is uncommitted adipose stromal cells may facilitate prolif-
eration rather than differentiation. Transforming growth factor β 1 (TGF-β 1) induces senescence in 
BM-MSCs via increases the mitochondrial reactive oxygen species production and also the ROS intra-
cellular production is associated with decreasing mitochondrial membrane potential, DNA damage 
and cell senescence32,33, this fact could explain that statistically significant (p < 0.05) decreasing of 
total ROS in pre-pubertal group because TGF-β 1 was found statistically significant (p < 0.05) low 
with respect to other groups in the iTRAQ analysis.
86 modulated proteins found in our iTRAQ analysis were involved in pluripotency process. Terme 
et al.34 showed that pluripotent cells had decreased levels of H1.0 and increased levels of H1.1, H1.3, 
and H1.5 compared with differentiated cells. Our results also indicated that H4 was statistically sig-
nificant decrease in adult group which could point towards their less pluripotency with respect to 
the other groups, differentiation of embryonic stem cells is accompanied by a global reduction of 
panacetylation of histones H3 and H4 suggesting that histone acetylation plays an important role in 
maintenance of embryonic stem cells pluripotency35. Results published by Bermeo et al.36 indicate 
that MSCs over-expressing Lamin A had higher oestrogenic and lower radiogenic differentiation 
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Figure 3. Validation of iTRAQ analysis. (A) Significant activates pathways obtained by comparing 
modulated proteins obtained by iTRAQ analysis employing functional annotations according to the String 
9.0 software. Small numbers on the right of each bar are the modulated protein involved in each process.  
(B) Western blot analysis of Lamin A/C, Vimentin and Superoxide dismutase 2 (SOD-2). Tubulin was used 
as housekeeping. On the left molecular weight of each protein is shown. On the bottom the group’s source of 
mesenchymal stem cells used. The gels have been run under the same experimental conditions. (C) Vinculin 
gene expression using real-time reverse transcriptase PCR (qRT-PCR) analysis normalized by expression of 
HPRT gene used as housekeeping.
potential. Their studies demonstrated that lamin A/C played a significant role in the differentiation 
towards both osteoblast and adipocyte lines by regulating some of the elements of Wnt/β -catenin sig-
naling during early MSCs differentiation, indicating that MSC over expressing Lamina A have higher 
osteogenic and lower adipogenic differentiation potential. Our results were coincident with Bermeo’s 
results, because of we found high levels of Lamina A/C by western in MSCs from adult group which 
we could link to lowest adipogenic potential with the statistically significant (p < 0.05) lowest levels 
of oil red staining during its directed differentiation (Fig. 2A,B). Also we consider the role of Lamin 
A like a senescence marker and its relationship whit increase of ROS37 together with increase of 
Thioredoxin found in our iTRAQ study in adult group could indicate the loss of functionality with 
age, it might be due to the accumulation of oxidative damage also induce because decrease of SOD2 
in this adult group. Stolzing et al.38 demonstrated that age influences impairment of mesenchymal 
progenitor cells function.
55 modulated proteins found were involved in energetic metabolism process. The decision to exit 
pluripotency and undergo differentiation is of singular importance for pluripotent cells, including MSCs. 
The molecular mechanisms for these decisions to differentiate, as well as reversing those decisions during 
induced pluripotency have focused largely on transcriptomic controls. Easley et al.39 explored the role of 
translational control for the maintenance of pluripotency and the decisions to differentiate. ATP-citrate 
synthase is deep linked to pentose phosphate route and its inhibition has been recently linked to a 
decrease in proliferation rate40. Also it has been reported by Pattapa et cols.41 that MSCs resided under 
hypoxic conditions which were associated with the inherent metabolism of the cells. However MSCs 
under normoxia growth conditions derived a significant proportion of ATP from oxidative phosphoryl-
ation in addition to glycolysis. The observed increase of LDH in MSCs from adult group (Fig. 4C) could 
be explained because this group also had the glycolysis increased, on the other way glycolysis decreased 
in pre-pubertal group. All these results have been supported with our results through pentose phosphate 
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pathway activity because of were significantly decreased G6PDH in pre-pubertal group and significantly 
increased in adult group (Fig. 4D).
Global protein translation is significantly reduced in hESCs compared to their differentiated progeny. 
mTOR is a Ser/Thr protein kinase that functions as an ATP and amino acid sensor to balance nutrient 
availability and cell growth42. mTOR regulates cellular senescence and drives bioenergetic infrastruc-
ture12. mTOR restrains proliferation potential of stem cells mediating their self-renewal loss, which is an 
effect that can be suppressed by mTOR-inhibitors, such as rapamicyn, antagonizing senescence43. mTOR 
plays an important role in the regulation of hematopoietic stem cell self-renewal in vitro and inhibition 
of mTOR hyperactivation with rapamycin may represent a novel approach to promote ex vivo expansion 
and their long-term hematopoietic reconstitution of hematopoietic stem cells44. Our results of mTOR 
family by western blot analysis indicated that mTOR (Fig.  5A,B) was statistically significant increased 
in adult group versus the other groups studied it could mean that MSCs from adult group were more 
Figure 4. Metabolism profile from rats mesenchymal stem cells at different age. (A) 2′ ,7′ - 
dichlorofluorescein signal measured by flow cytometry to check ROS intracellular (B) Mitosox signal 
measured by flow cytometry to check ROS mitochondrial. (C) Lactate-dehydrogenase (LDH) activity 
measured by spectrophotometer analysis. (D) Pentose phosphate pathway activity measured by spectrometer 
analysis. G6PDH = Glucose-6-phosphate 1-dehydrogenase; 6GPDH = 6-phosphogluconate-dehydrogenase. 
*p value less than 0.01 compared with previous group and #p value less than 0.05 compared with previous 
group, were considered statistically significant using Mann-Whitney-U tests.
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Figure 5. mTOR pathway profile from rat mesenchymal stem cells at different age (A) Western blot of 
mTOR pathway, mTOR and raptor, Tubulin was used as housekeeping. (B) Densitometry analysis of westerns 
of mTOR normalized with respect to Tubulin. *p value less than 0.01 compared with previous group. (C) 
Tetramethylrhodamine, methyl ester (TMRM) dye accumulated in active mitochondria with intact potentials, 
was used to detect functional mitochondria in the MSCs at different ages following functional mitochondrial 
staining protocol from commercial. (D) Viability assay of mesenchymal stem cells from adult group incubated 
with 10 μ M or 5 μ M of imatinib mesylate or 1 ng/ml or 0.1 ng/ml of JK184. (E) Flow cytometry of Ki67 from 
mesenchymal stem cells of adult group incubated with 1 ng/ml or 0.1 ng/ml of JK184 in the medium. F) Western 
blot of mTOR and Tubulin of mesenchymal stem cells from adult group after incubating with 10 μ M or 5 μ M of 
imatinib mesylate or 1 ng/ml or 0.1 ng/ml of JK184 in the medium. Control = mesenchymal stem cells incubated 
with growth medium alone. The gels have been run under the same experimental conditions. *p value less than 
0.01 compared with control group was considered statistically significant using Mann-Whitney-U tests.
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senescence than MSCs from younger groups and this result was corroborated by expression of Lamin 
A/C in adult group in front at no expression of Lamin A in the other groups (Fig. 3B) together with less 
expression of TMRM (Fig. 5C) in adult group.
We found correlation between inhibition of mTOR and decrease of CD117 and Ki67 which are pro-
liferation markers in the literature45,46 and we wonder if this relationship between mTOR pathway and 
proliferation was present when the proliferation markers were inhibited by specific reagents. Our results 
using inhibitors of CD117 and Ki67, imatinib mesylate and JK184 respectively, indicated that mTOR 
pathway can be modified through modification of proliferation markers, because the MSCs from adult 
group was treated with the Ki67 inhibitor at two physiological dose which do not affected their viability 
(Fig.  5D) but the expression of mTOR was modified when the proliferation marker Ki67 and CD117 
were diminished (Fig. 5F).
Conclusions
The importance of our study lies in the fact that age from the MSCs source directly influences their dif-
ferentiation, proliferative and metabolism profiles and also it is the first time where is shown the direct 
influence of proliferative markers CD117 and Ki67 on activation of mTOR pathway. Summary we affirm 
that young group of rats has the most proliferative and pluripotent MSCs be able to future functional 
studies.
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